Work

Utility of a US Food and Drug Administration (FDA) label indication for condoms for anal sex

Year: 2019

Type: article

Study design: Observational Study

Abstract: Condoms are highly effective for HIV prevention, yet are not currently indicated by the US Food and Drug Administration (FDA) for anal sex. We surveyed a national sample of men who have sex with men to assess whether FDA label indication could affect anticipated condom use, and to determine levels of perceived condom failure for anal sex. We found that 69% of respondents anticipated that a label indication change would increase their likelihood of condom use. Median perceived failure was 15%. We anticipate that these results may aid the FDA in developing standards for a label indication for anal sex.

Source: Sexual Health

DOI: 10.1071/sh18152

Authors: Aaron J. Siegler, Lauren Ahlschlager, Elizabeth M. Rosenthal, Patrick S. Sullivan, Colleen F. Kelley, Eli S. Rosenberg, Travis H. Sanchez, Reneé H. Moore, C. Christina Mehta, Michael P. Cecil

Institutions: Emory University, University at Albany, State University of New York

Language: English

Topic: HIV/AIDS Research and Interventions

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Funders: Small Business Innovation Research, Emory University, National Institutes of Health, Center for AIDS Research, University of Washington, National Institute of Allergy and Infectious Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: G183157880, G2675028044, Behavioral and Manufacturing Science to Commercially Develop Fitted Condoms, A study to improve the fit of HIV prevention methods, G6113675784, G9000102070

OpenAlex ID: W2980815350

FWCI: 0.384

Cites: 6

Cited by: 2

Related to: 10